EcoR1 Capital, LLC Q1 2024 Filing
Filed May 15, 2024
Portfolio Value
$4.0B
Holdings
57
Report Date
Q1 2024
Filing Type
13F-HR
All Holdings (57 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | APLSAPELLIS PHARMACEUTICALS INC | 11,357,425 | $667.6T | 16885139.32% | |
| 2 | PRTAPROTHENA CORP PLC | 11,584,280 | $286.9T | 7257553.44% | |
| 3 | ARVNARVINAS INC | 6,726,491 | $277.7T | 7023012.51% | |
| 4 | SRPTSAREPTA THERAPEUTICS INC | 1,919,835 | $248.5T | 6286294.11% | |
| 5 | CRNXCRINETICS PHARMACEUTICALS IN | 4,155,375 | $194.5T | 4919761.54% | |
| 6 | GLPGGALAPAGOS NV | 5,756,268 | $185.4T | 4688048.19% | |
| 7 | ANABANAPTYSBIO INC | 7,521,024 | $169.4T | 4283912.07% | |
| 8 | ZYMEZYMEWORKS INC | 13,437,473 | $141.4T | 3575432.09% | |
| 9 | KURAKURA ONCOLOGY INC | 6,506,871 | $138.8T | 3510413.21% | Call |
| 10 | JAZZJAZZ PHARMACEUTICALS PLC | 1,013,952 | $122.1T | 3088241.17% | |
| 11 | XNCRXENCOR INC | 5,330,416 | $118.0T | 2983580.13% | |
| 12 | ACADACADIA PHARMACEUTICALS INC | 5,991,479 | $110.8T | 2801987.17% | |
| 13 | TNGXTANGO THERAPEUTICS INC | 13,330,736 | $105.8T | 2677132.21% | |
| 14 | IMNMIMMUNOME INC | 3,879,415 | $95.7T | 2421623.29% | |
| 15 | CRSPCRISPR THERAPEUTICS AG | 1,389,276 | $94.7T | 2395042.93% | |
| 16 | —MERSANA THERAPEUTICS INC | 19,364,688 | $86.8T | 2194237.87% | |
| 17 | MORFMORPHIC HLDG INC | 2,384,384 | $83.9T | 2122824.31% | |
| 18 | NUVBNUVATION BIO INC | 19,209,643 | $69.9T | 1768544.00% | |
| 19 | NGNENEUROGENE INC | 1,271,342 | $64.7T | 1636723.68% | |
| 20 | CNTACENTESSA PHARMACEUTICALS PLC | 5,618,779 | $63.5T | 1605889.23% | |
| 21 | ORICORIC PHARMACEUTICALS INC | 3,418,068 | $47.0T | 1188717.31% | |
| 22 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 27,404,070 | $43.3T | 1095134.22% | |
| 23 | TCRXTSCAN THERAPEUTICS INC | 5,000,000 | $39.7T | 1004120.18% | |
| 24 | VYGRVOYAGER THERAPEUTICS INC | 3,917,546 | $36.5T | 922484.27% | |
| 25 | THRDTHIRD HARMONIC BIO INC | 3,182,444 | $30.0T | 759850.14% | |
| 26 | NMRANEUMORA THERAPEUTICS INC. | 2,071,450 | $28.5T | 720397.75% | |
| 27 | TCE2CELLDEX THERAPEUTICS INC | 650,000 | $27.3T | 689997.50% | |
| 28 | 5E7ITEOS THERAPEUTICS INC | 1,999,249 | $27.3T | 689725.75% | |
| 29 | LENZLENZ THERAPEUTICS INC | 1,219,774 | $27.2T | 688911.25% | |
| 30 | AVIRATEA PHARMACEUTICALS INC | 6,145,861 | $24.8T | 627999.47% | |
| 31 | ALECALECTOR INC | 4,056,548 | $24.4T | 617658.33% | |
| 32 | EWTXEDGEWISE THERAPEUTICS INC | 1,250,385 | $22.8T | 576851.16% | |
| 33 | NKTXNKARTA INC | 2,000,000 | $21.6T | 546828.17% | |
| 34 | PHVSPHARVARIS N V | 900,000 | $20.8T | 526062.86% | |
| 35 | PCVXVAXCYTE INC | 300,000 | $20.5T | 518323.30% | |
| 36 | MDGLMADRIGAL PHARMACEUTICALS INC | 75,000 | $20.0T | 506562.19% | |
| 37 | RNAAVIDITY BIOSCIENCES INC | 757,576 | $19.3T | 488992.36% | |
| 38 | OVIDOVID THERAPEUTICS INC | 6,117,400 | $18.7T | 471912.96% | |
| 39 | VERVVERVE THERAPEUTICS INC | 1,250,000 | $16.6T | 419858.82% | |
| 40 | KROSKEROS THERAPEUTICS INC | 187,500 | $12.4T | 313945.64% | |
| 41 | DYNDYNE THERAPEUTICS INC | 427,039 | $12.1T | 306639.51% | |
| 42 | KYTXKYVERNA THERAPEUTICS INC | 450,000 | $11.2T | 282721.80% | |
| 43 | GOSSGOSSAMER BIO INC | 9,195,404 | $10.9T | 274440.39% | |
| 44 | KODKODIAK SCIENCES INC | 1,664,700 | $8.8T | 221471.02% | Call |
| 45 | —ALLOVIR INC | 11,294,585 | $8.5T | 215652.69% | |
| 46 | GBIOGBXGENERATION BIO CO | 2,046,867 | $8.3T | 210707.13% | |
| 47 | ATRAGBXATARA BIOTHERAPEUTICS INC | 10,167,043 | $7.1T | 178463.47% | |
| 48 | PRQRPROQR THRAPEUTICS N V | 2,884,357 | $6.6T | 167055.47% | |
| 49 | ALGSALIGOS THERAPEUTICS INC | 6,389,468 | $6.3T | 158374.77% | |
| 50 | ARQTARCUTIS BIOTHERAPEUTICS INC | 500,000 | $5.0T | 125325.33% | |
| 51 | PRMEPRIME MEDICINE INC | 700,000 | $4.9T | 123934.23% | |
| 52 | NUVB/WSNUVATION BIO INC | 963,333 | $3.5T | 88689.66% | |
| 53 | HOOKGBPHOOKIPA PHARMA INC | 4,595,024 | $3.3T | 82749.04% | |
| 54 | SRZNWSURROZEN INC | 66,665 | $1.0T | 26489.22% | |
| 55 | PMVPPMV PHARMACEUTICALS INC | 566,879 | $963.7B | 24374.42% | |
| 56 | —CAREMAX INC | 100,000 | $482.0B | 12191.08% | |
| 57 | NVLSEURALPINE IMMUNE SCIENCES INC | 1,000 | $39.6B | 1002.60% |